Artificial Insemination Market Size, Share, Growth Analysis, By Type (Intrauterine, Intravaginal), By Source Type (AIH-Husband, AID-Donor), By End Use (Fertility Clinics, Other Facilities), By Region -Industry Forecast 2024-2031.


Report ID: SQMIG35A2961 | Region: Global | Published Date: October, 2024
Pages: 159 |Tables: 87 |Figures: 71

Artificial Insemination Market Insights

Global Artificial Insemination Market size was valued at USD 2.1 billion in 2022 and is poised to grow from USD 2.2 billion in 2023 to USD 3.8 billion by 2031, growing at a CAGR of 8.01% during the forecast period (2024-2031).

The major growth drivers for the market include an increasing demand for assisted reproductive technologies and surging incidence of infertility. With the rapid changes in lifestyle and incidence of medical conditions such as endometriosis and PCOS, artificial insemination techniques are needed, hence driving the growth of the market. Increasing access and acceptance of artificial insemination in developing countries further confirms this. Technical development has also provided ways for the growth of the industry in forms such as an improved method for the selection of sperm and eggs, cryopreservation, and pre-implantation genetic testing.

In addition, same-sex marriage, acceptance of LGBT parenthood, the availability of donor sperm and eggs, and medical technology are believed to lead the industry to further growth. Moreover, the market is growing because of more enabling policies to support this, awareness, and education campaigns on artificial insemination and infertility issues are rising, and there is increased demand for personalized and customized treatments. Other factors beneficially affecting the market growth include the availability of insurance coverage for the procedure, the trend for delaying childbearing to pursue professional goals, and more clinics and medical institutions performing artificial insemination.

Market Snapshot - 2024-2031

Global Market Size

USD 2.1 billion

Largest Segment

Fertility clinics

Fastest Growth

Intracervical

Growth Rate

8.01%

Global Artificial Insemination Market ($ Bn)
Country Share for Europe Region (%)

To get more reports on the above market click here to Buy The Report

Artificial Insemination Market Segmental Analysis

The Global Artificial Insemination Market is segmented into Type, Source Type, End Use, and Region. Based on Type, the market is segmented into Intrauterine, Intracervical, Intravaginal, and Intratubal. Based on Source Type, the market is segmented into AIH-Husband and AID-Donor. Based on End Use, it is segmented into Fertility Clinics & Other Facilities, and Home. Based on Region, the market is segmented into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. 

Analysis By Type

The intrauterine insemination segment held the largest share of the market and is bound to continue holding the top spot among industries. In comparison with other fertility procedures, it gives a huge chance for pregnancy by directly depositing the sperm in the uterus. This is one of the easier treatments and presents some of the highest conception rates, making it the treatment of choice for many couples with infertility problems. Advancement in reproductive technology is predicted to continue favoring the segment as the fastest growing during the forecast period due to high success rates and low levels of intervention associated with IUI.

However, Intravaginal insemination is anticipated to be the second-largest segment of the artificial insemination market. IVM/IVI procedures are flexible and convenient, in the sense that they may be conducted in the comfort of one's own home or reproductive clinics, especially if donor insemination or surrogacy is the case. In this form of conception, sperm is injected into the vaginal canal to facilitate spontaneous conception. Accessibility and ease of use that can suit different individual situations and medical conditions comprise its key strengths. This market positioning of IVI is expected to rise due to necessary substitution brought about by increasing demand for more personalized, minimally invasive reproductive options.

Analysis By Source Type

AIH-Husband dominated owing to high effectiveness and affordability in childless couples. AIH procedures bypass all obstacles to normal conception and fertilize the egg directly with the partner's sperm. Due to its high success rate and relatively simpler technique, AIH can be expected to grow the fastest among the fertility treatments in the forecast period. Some of the factors encouraging the wider practice of the procedure include the increased awareness among childless couples of the benefits associated with AIH and the improvement in reproductive technology. Due to this fact, AIH remains one of the favored options for numerous childless couples who strive to seek efficient ways of overcoming infertility.

AID-Donor has often proved to be a last resort for many childless couples who may suffer extreme infertility problems, such as dead or immobile sperm. It could be a viable alternative for same-sex couples and unmarried women who want to get pregnant. AID involves the use of donor sperm, which is highly regulated and provided by sperm banks in order that all the extensive family medical history and personal health are known about the donors. This guarantees an extremely high level of reliability and safety for this method. Adoption and use of AID were expected to grow with the increasing level of change in cultural views regarding the dynamics of family and reproduction. However, this section remains an essential provision for those people unable to conceive naturally or require other means of getting pregnant.

Global Artificial Insemination By Source Type

To get detailed analysis on other segments, Request For Free Sample Report

Artificial Insemination Market Regional Insights

A severe decline in fertility rates across the continent witnessed Europe emerge as the biggest regional market. The decline is blamed on a change in cultural norms, different priorities, and late pregnancies on account of professional and lifestyle reasons. This, in turn, has created a growing demand for better fertility treatments as many European countries wrestle with decreasing birth rates to help people and couples attain their reproductive goals. There is, therefore, a significant market in fertility services and solutions that aim to reverse the trends or at least encourage family planning through advanced therapies and technologies due to the continued decline in birth rates.

North America accounted for the second-largest market in fertility treatments due to its fertility rate of just 62.5 births per 1,000 women, according to statistics from the National Center for Health Statistics. The comparatively low birth rate reflects the persistence of this region's problems, such as postponed childbearing and lifestyle decisions impinging on reproductive health. Despite this, North America remains one of the largest contributors to the fertility industry, because there is high demand for advanced reproductive technology and therapies. The region has a massive number of fertility options catering to both medical and personal requirements, enabled by its high-end health infrastructure and relatively higher level of awareness on alternatives related to fertility. These factors cumulatively account for the region's large market presence.

Global Artificial Insemination Market By Geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Artificial Insemination Market Dynamics

Drivers

Increasing Infertility Rates

  • Going up is the infertility rates across the globe, which is working as an imperative for the artificial insemination market. Artificial insemination, to a large extent, has become a necessity of the day because of delayed conception, changing lifestyles, environmental issues, and the growing disorders related to the reproductive organ. Only assisted reproductive technology can provide solutions to couples and individuals not able to conceive naturally. These challenges can be overcome with artificial insemination, which will contribute to better adoption of the procedure. Moreover, increased awareness and acceptability of fertility treatments, along with a greater interest from more people in such advanced methods for their reproductive goals, encourage the market.

Technological Advancement

  • Significant technological advances in reproductive health drive the market for artificial insemination. Enhancements in sperm processing procedures, hormone therapy, and monitoring and diagnostic technologies further the success rate and efficiency of the artificial insemination processes. These make the procedure less invasive and more comfortable for the patients, while raising the chances of a healthy pregnancy. The continuous innovation of new techniques and technology of artificial insemination expands the possibilities available to singletons and pairs, which encourages the acceptance and growth of the market.

Restraints

High Costs of Artificial Insemination Services

  • Artificial insemination operations are very costly for most people and couples. The cost of multiple cycles of treatment, medicines, and other medical expenses may be beyond the reach of many individuals, especially in regions where insurance coverage for infertility treatments is limited. This cost factor will make artificial insemination unreachable, especially to people of low-income status. For overcoming this challenge and making sure more people have access to these reproductive options, actions directed towards affordability by cost reduction need to be taken.

Social and Ethical Concerns

  • Artificial insemination ethical and social issues may hamper the growth of the market. Donor sperm, the risk of embryo genetic selection, and the welfare implications for children born by artificial insemination raise difficult ethical issues. Moral debates may affect public perception and, therefore, acceptance of these types of treatments, which may have a demand impact. Indeed, these can only be assuaged through ethical principles and open procedures if the technology of artificial insemination is ever going to gain wider acceptance and build confidence.

Request Free Customization of this report to help us to meet your business objectives.

Artificial Insemination Market Competitive Landscape

The report involves an in-depth study of the competitive environment surrounding the global artificial insemination market. The competition analysis included within the study covers market structure, market share by major players, player positioning, top winning strategies, competitive dashboard, and business assessment quadrant. It includes detailed profiles for all major companies.

Top Player’s Company Profiles

  • Conceivex Inc. 
  • FUJIFILM Irvine Scientific Inc. 
  • Genea Limited 
  • Genus plc 
  • Zoetis Inc. 
  • Inguran LLC 
  • ABS Global 
  • Hamilton Thorne Inc. 
  • Hi-Tech Solutions 
  • Kitazato Corporation 
  • Pride Angel 
  • Rinovum Women’s Health LLC 
  • Rocket Medical plc 
  • TenderNeeds Fertility LLC 
  • Vitrolife AB 
  • Imv Technologies 
  • Neogen Corporations 
  • Agtech inc 
  • Continental Genetics 
  • Select Series

Recent Developments

  • In January 2024, CooperSurgical, one of the leading players in the artificial insemination market, introduced an AI-powered fertility tracking system to improve the accuracy and efficiency of AI treatment. The new technology can provide more accurate monitoring of ovulation cycles, sperm quality, and embryo development by amalgamating artificial intelligence with advanced imaging and diagnostic techniques.
  • In May 2021, the 10th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE) was held virtually to provide deep insights into recent advances and possible applications of AI in assisted reproductive technologies.
  • In February 2020, the Union Cabinet of India approved the Assistive Reproductive Technology Regulation Bill 2020 to regulate and supervise clinics offering safe and ethical ART treatment to infertile couples.

Artificial Insemination Key Market Trends

  • Increasing Utilization of Advanced Reproductive Technologies: Artificial insemination treatment combines less invasive techniques with advanced reproductive technology to maximize the conception rate. Included in these are advanced techniques in genetic screening and cryopreservation, high-tech sperm treatment and processing techniques, and many others. One such instance includes preimplantation genetic testing, which is the genetic scanning of embryos before implantation to eliminate the possibility of a genetic disorder in the child. Moreover, patients are given more options and leeway because of advancements in the areas of sperm freezing and thawing. The rationale behind the technological advances is to extend growth and expansion into the market by having better, more personalized treatment procedures and higher success rates for artificial insemination operations.
  • Greater amount of personalized and patient-oriented care: Artificial insemination has increasingly favored the trend toward personalized, patient-centered treatment modalities. Most fertility clinics in modern times use treatment plans that are specifically tailored to each patient's health profile, genetic information, and specific reproductive issues. This means formulating tailor-made treatment programs for every patient based on what is learned from the data. The move is toward individualized care, be it for patients' happiness or rising success rates. In addition, digital health platforms and telemedicine continue to emerge, promoting better communication between patients and providers, thus allowing for the management of care in a flexible and responsive manner throughout the artificial insemination process.

Artificial Insemination Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.  

As per SkyQuest analysis, along with the increase in infertility rates, due to the emerging reproductive technologies, the artificial insemination market is expected to continue to rise. Innovations, such as AI-powered monitoring systems and personalized treatment plans, further increase efficacy and access to artificial insemination by offering tailored solutions to meet the range of patient needs. However, the market still faces even more challenges in costs and ethics that need to be surpassed for there to be ample access and acceptance. Artificial insemination is going to continue to play a significant part in aiding the individual and couple with the realization of their reproductive objectives in the future as even further growth and expansion of the industry testify to the fact that the market continues evolving due to changing circumstances of patient-oriented care and new technologies.

Report Metric Details
Market size value in 2022 USD 2.1 billion
Market size value in 2031 USD 3.8 billion
Growth Rate 8.01%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Type
    • Intrauterine, Intracervical, Intravaginal, and Intratubal
  • Source Type
    • AIH-Husband and AID-Donor
  • End user
    • Fertility clinics, Home & other facilities
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Conceivex Inc. 
  • FUJIFILM Irvine Scientific Inc. 
  • Genea Limited 
  • Genus plc 
  • Zoetis Inc. 
  • Inguran LLC 
  • ABS Global 
  • Hamilton Thorne Inc. 
  • Hi-Tech Solutions 
  • Kitazato Corporation 
  • Pride Angel 
  • Rinovum Women’s Health LLC 
  • Rocket Medical plc 
  • TenderNeeds Fertility LLC 
  • Vitrolife AB 
  • Imv Technologies 
  • Neogen Corporations 
  • Agtech inc 
  • Continental Genetics 
  • Select Series
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

 

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Artificial Insemination Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Artificial Insemination Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Artificial Insemination Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Artificial Insemination Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Artificial Insemination Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Artificial Insemination Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Global Artificial Insemination Market size was valued at USD 2.1 billion in 2022 and is poised to grow from USD 2.2 billion in 2023 to USD 3.8 billion by 2031, growing at a CAGR of 8.01% during the forecast period (2024-2031).

The report involves an in-depth study of the competitive environment surrounding the global artificial insemination market. The competition analysis included within the study covers market structure, market share by major players, player positioning, top winning strategies, competitive dashboard, and business assessment quadrant. It includes detailed profiles for all major companies. 'Conceivex Inc. ', 'FUJIFILM Irvine Scientific Inc. ', 'Genea Limited ', 'Genus plc ', 'Zoetis Inc. ', 'Inguran LLC ', 'ABS Global ', 'Hamilton Thorne Inc. ', 'Hi-Tech Solutions ', 'Kitazato Corporation ', 'Pride Angel ', 'Rinovum Women’s Health LLC ', 'Rocket Medical plc ', 'TenderNeeds Fertility LLC ', 'Vitrolife AB ', 'Imv Technologies ', 'Neogen Corporations ', 'Agtech inc ', 'Continental Genetics ', 'Select Series'

Going up is the infertility rates across the globe, which is working as an imperative for the artificial insemination market. Artificial insemination, to a large extent, has become a necessity of the day because of delayed conception, changing lifestyles, environmental issues, and the growing disorders related to the reproductive organ. Only assisted reproductive technology can provide solutions to couples and individuals not able to conceive naturally. These challenges can be overcome with artificial insemination, which will contribute to better adoption of the procedure. Moreover, increased awareness and acceptability of fertility treatments, along with a greater interest from more people in such advanced methods for their reproductive goals, encourage the market.

Increasing Utilization of Advanced Reproductive Technologies: Artificial insemination treatment combines less invasive techniques with advanced reproductive technology to maximize the conception rate. Included in these are advanced techniques in genetic screening and cryopreservation, high-tech sperm treatment and processing techniques, and many others. One such instance includes preimplantation genetic testing, which is the genetic scanning of embryos before implantation to eliminate the possibility of a genetic disorder in the child. Moreover, patients are given more options and leeway because of advancements in the areas of sperm freezing and thawing. The rationale behind the technological advances is to extend growth and expansion into the market by having better, more personalized treatment procedures and higher success rates for artificial insemination operations.

A severe decline in fertility rates across the continent witnessed Europe emerge as the biggest regional market. The decline is blamed on a change in cultural norms, different priorities, and late pregnancies on account of professional and lifestyle reasons. This, in turn, has created a growing demand for better fertility treatments as many European countries wrestle with decreasing birth rates to help people and couples attain their reproductive goals. There is, therefore, a significant market in fertility services and solutions that aim to reverse the trends or at least encourage family planning through advanced therapies and technologies due to the continued decline in birth rates.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Artificial Insemination Market

Report ID: SQMIG35A2961

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE